Source:http://linkedlifedata.com/resource/pubmed/id/11426532
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007600,
umls-concept:C0035647,
umls-concept:C0035820,
umls-concept:C0040715,
umls-concept:C0079189,
umls-concept:C0205210,
umls-concept:C0206180,
umls-concept:C0332256,
umls-concept:C0599718,
umls-concept:C0599813,
umls-concept:C0599893,
umls-concept:C0883208,
umls-concept:C1515757,
umls-concept:C1522702
|
pubmed:issue |
5-6
|
pubmed:dateCreated |
2001-6-27
|
pubmed:abstractText |
A permanent cell line, HSC-M1, was established from a child with advanced CD30 (Ki-1)+ anaplastic large-cell lymphoma (ALCL). Clinical features included irritability, fever, weight loss, tender lymphadenopathy, pneumonitis, neutrophilia, and bone marrow erythrophagocytosis. While HSC-M1 cells exhibited an immunophenotype characteristic of ALCL of T-cell lineage, the cell line also demonstrated features of monocyte-macrophage lineage. Cytogenetic and polymerase chain reaction (PCR) analysis of the HSC-M1 cell line and involved bone marrow demonstrated the characteristic non-random chromosomal translocation t(2:5)(p23:q35). Reverse transcriptase PCR for mRNA expression of cytokines and cytokine receptors showed that HSC-M1 cells expressed the message for multiple cytokines and their receptors. Measurement of cytokine levels in serum samples using enzyme-linked immunosorbent assays showed increased concentrations of several cytokines. The increased levels of some cytokines correlated with disease activity and clinical symptoms. Although spontaneous production by HSC-M1 cells of some of these cytokines was demonstrated, the production of others was only detectable after stimulation with exogenous CD30 ligand. With few exceptions, there was good correlation between serum cytokine levels and cytokines produced by HSC-M1 cells. These findings indicate that cytokine production is a feature of ALCL cells and that some of the clinical manifestations in ALCL may result from cytokines produced by either the malignant or accessory cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
599-611
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11426532-Chromosomes, Human, Pair 2,
pubmed-meshheading:11426532-Chromosomes, Human, Pair 5,
pubmed-meshheading:11426532-Cytokines,
pubmed-meshheading:11426532-Humans,
pubmed-meshheading:11426532-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:11426532-Translocation, Genetic,
pubmed-meshheading:11426532-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: potential role of cytokines in clinical manifestations.
|
pubmed:affiliation |
Department of Pediatrics, University of Toronto and The Hospital for Sick Children, Ontario, Canada.
|
pubmed:publicationType |
Journal Article
|